Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

VTCN1 Antikörper (Internal Region)

VTCN1 Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
Produktnummer ABIN547972
  • Target Alle VTCN1 Antikörper anzeigen
    VTCN1 (V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))
    Bindungsspezifität
    • 16
    • 15
    • 7
    • 7
    • 7
    • 6
    • 6
    • 6
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Internal Region
    Reaktivität
    • 84
    • 22
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 71
    • 12
    • 2
    • 2
    Ziege
    Klonalität
    • 67
    • 19
    • 1
    Polyklonal
    Konjugat
    • 29
    • 11
    • 8
    • 5
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Dieser VTCN1 Antikörper ist unkonjugiert
    Applikation
    • 56
    • 37
    • 31
    • 27
    • 26
    • 15
    • 8
    • 8
    • 7
    • 6
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Verwendungszweck
    Goat polyclonal antibody raised against synthetic peptide of VTCN1.
    Sequenz
    C-SKGKGNANLE YK
    Kreuzreaktivität
    Hund, Human, Maus, Ratte
    Immunogen
    A synthetic peptide corresponding to internal region of human VTCN1.
    Top Product
    Discover our top product VTCN1 Primärantikörper
  • Applikationshinweise
    ELISA (1:64000)
    Western Blot (0.5-1.5 μg/mL)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.5 mg/mL
    Buffer
    In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Krambeck, Thompson, Dong, Lohse, Park, Kuntz, Leibovich, Blute, Cheville, Kwon: "B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 27, pp. 10391-6, (2006) (PubMed).

  • Target
    VTCN1 (V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))
    Andere Bezeichnung
    VTCN1 / B7H4 (VTCN1 Produkte)
    Synonyme
    B7h4 antikoerper, B7s1 antikoerper, B7x antikoerper, BC032925 antikoerper, B7-H4 antikoerper, B7H4 antikoerper, B7S1 antikoerper, B7X antikoerper, B7h.5 antikoerper, PRO1291 antikoerper, VCTN1 antikoerper, RGD1311204 antikoerper, V set domain containing T cell activation inhibitor 1 L homeolog antikoerper, V-set domain containing T cell activation inhibitor 1 antikoerper, V-set domain containing T-cell activation inhibitor 1 antikoerper, V set domain containing T cell activation inhibitor 1 antikoerper, vtcn1.L antikoerper, VTCN1 antikoerper, vtcn1 antikoerper, Vtcn1 antikoerper
    Gen-ID
    79679
Sie sind hier:
Kundenservice